APA

Dbouk H., Ajouz H., Shamseddine A., Mukherji D., O'Reilly E. M., Haydar A., Kelsen D., Naghy M., Eloubeidi M., Geara F., Saltz L. & Abou-Alfa G. K. (20131022). Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer. : Gastrointestinal cancer research : GCR.

Chicago

Dbouk Haifa, Ajouz Hana, Shamseddine Ali, Mukherji Deborah, O'Reilly Eileen M, Haydar Ali, Kelsen David, Naghy Mohamed, Eloubeidi Mohamed, Geara Fadi, Saltz Leonard and Abou-Alfa Ghassan K. 20131022. Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer. : Gastrointestinal cancer research : GCR.

Harvard

Dbouk H., Ajouz H., Shamseddine A., Mukherji D., O'Reilly E. M., Haydar A., Kelsen D., Naghy M., Eloubeidi M., Geara F., Saltz L. and Abou-Alfa G. K. (20131022). Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer. : Gastrointestinal cancer research : GCR.

MLA

Dbouk Haifa, Ajouz Hana, Shamseddine Ali, Mukherji Deborah, O'Reilly Eileen M, Haydar Ali, Kelsen David, Naghy Mohamed, Eloubeidi Mohamed, Geara Fadi, Saltz Leonard and Abou-Alfa Ghassan K. Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer. : Gastrointestinal cancer research : GCR. 20131022.